Cargando…

Change in arterial tumor perfusion is an early biomarker of lenvatinib efficacy in patients with unresectable hepatocellular carcinoma

BACKGROUND: Lenvatinib is one of the ﬁrst-line tyrosine kinase inhibitors used for unresectable hepatocellular carcinoma (HCC). In the present study, we evaluated the potential of early changes in the time-intensity curve (TIC) of arterial phase on contrast-enhanced ultrasound (CEUS) as early imagin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kuorda, Hidekatsu, Abe, Tamami, Fujiwara, Yudai, Okamoto, Takuya, Yonezawa, Miki, Sato, Hiroki, Endo, Kei, Oikawa, Takayoshi, Sawara, Kei, Takikawa, Yasuhiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2019
Materias:	Prospective Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6529888/ https://www.ncbi.nlm.nih.gov/pubmed/31148907 http://dx.doi.org/10.3748/wjg.v25.i19.2365

Ejemplares similares

Impact of Grip Strength in Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib
por: Endo, Kei, et al.
Publicado: (2020)

Comparing the Safety and Efficacy of Microwave Ablation Using Thermosphere(TM) Technology versus Radiofrequency Ablation for Hepatocellular Carcinoma: A Propensity Score-Matched Analysis
por: Kuroda, Hidekatsu, et al.
Publicado: (2021)

Hepatic Angiomyolipoma Staining in the Post-vascular Phase of Contrast-enhanced Ultrasound Due to the Presence of Macrophages
por: Endo, Kei, et al.
Publicado: (2017)

Contrast‐Enhanced Ultrasonography–Based Hepatic Perfusion for Early Prediction of Prognosis in Acute Liver Failure
por: Kuroda, Hidekatsu, et al.
Publicado: (2021)

Immune Checkpoint Inhibitor-Related Pneumonia in Unresectable Hepatocellular Carcinoma: Two Fatal Cases under Atezolizumab plus Bevacizumab
por: Endo, Kei, et al.
Publicado: (2022)

Influence of skeletal muscle volume loss during lenvatinib treatment on prognosis in unresectable hepatocellular carcinoma: a multicenter study in Tohoku, Japan
por: Fujita, Masashi, et al.
Publicado: (2022)

Two-dimensional shear wave elastography and ultrasound-guided attenuation parameter for progressive non-alcoholic steatohepatitis
por: Kuroda, Hidekatsu, et al.
Publicado: (2021)

Objective Response by mRECIST to Initial Lenvatinib Therapy Is an Independent Factor Contributing to Deep Response in Hepatocellular Carcinoma Treated with Lenvatinib-Transcatheter Arterial Chemoembolization Sequential Therapy
por: Kuroda, Hidekatsu, et al.
Publicado: (2022)

Conservative treatment of an aortoesophagial fistula after endovascular stent grafting for a thoracic aortic aneurysm
por: Kasai, Kazuhiro, et al.
Publicado: (2011)

A Novel Standard for Hepatocellular Carcinoma Screening Intensity After Hepatitis C Elimination
por: Miyasaka, Akio, et al.
Publicado: (2021)

Decreased Mean Kurtosis in the Putamen is a Diagnostic Feature of Minimal Hepatic Encephalopathy in Patients with Cirrhosis
por: Sato, Takuro, et al.
Publicado: (2019)

Analysis of Survival and Response to Lenvatinib in Unresectable Hepatocellular Carcinoma
por: Amioka, Kei, et al.
Publicado: (2022)

Shear wave dispersion to assess liver disease progression in Fontan-associated liver disease
por: Nagasawa, Tomoaki, et al.
Publicado: (2022)

Therapeutic efficacy of lenvatinib in nonviral unresectable hepatocellular carcinoma
por: Tomonari, Tetsu, et al.
Publicado: (2021)

Analysis of Lenvatinib’s Efficacy against Intermediate-Stage Unresectable Hepatocellular Carcinoma
por: Amioka, Kei, et al.
Publicado: (2022)

Annual changes in grip strength and skeletal muscle mass in chronic liver disease: observational study
por: Endo, Kei, et al.
Publicado: (2023)

Therapeutic Efficacy and Safety of Lenvatinib after Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma
por: Yano, Shigeki, et al.
Publicado: (2023)

Safety and efficacy of glecaprevir and pibrentasvir in north Tohoku Japanese patients with genotype 1/2 hepatitis C virus infection
por: Miyasaka, Akio, et al.
Publicado: (2022)

Impact of lenvatinib on renal function compared to sorafenib for unresectable hepatocellular carcinoma
por: Sasaki, Ryu, et al.
Publicado: (2022)

Prospect of lenvatinib for unresectable hepatocellular carcinoma in the new era of systemic chemotherapy
por: Sho, Takuya, et al.
Publicado: (2021)

Role of dynamic perfusion magnetic resonance imaging in patients with local advanced rectal cancer
por: Ippolito, Davide, et al.
Publicado: (2020)

Lenvatinib for the treatment of unresectable hepatocellular carcinoma: evidence to date
por: Personeni, Nicola, et al.
Publicado: (2019)

Successful Lenvatinib Re-challenge following Atezolizumab Plus Bevacizumab Combination Therapy Failure for Unresectable Hepatocellular Carcinoma
por: Kosaka, Yumi, et al.
Publicado: (2022)

Novel multi-parametric diagnosis of non-alcoholic fatty liver disease using ultrasonography, body mass index, and Fib-4 index
por: Funada, Kei, et al.
Publicado: (2023)

Conversion therapy for unresectable hepatocellular carcinoma after lenvatinib: Three case reports
por: Tomonari, Tetsu, et al.
Publicado: (2020)

The Real-world Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir for Hepatitis C Genotype 1
por: Miyasaka, Akio, et al.
Publicado: (2018)

Lenvatinib as a Therapeutic Option in Unresectable Metastatic Pheochromocytoma and Paragangliomas
por: Hassan Nelson, Lauren, et al.
Publicado: (2022)

Impact of combining Lenvatinib with Transarterial chemoembolization for unresectable hepatocellular carcinoma
por: Long, Jianwu, et al.
Publicado: (2023)

Clinical usefulness of geriatric assessment in elderly patients with unresectable hepatocellular carcinoma receiving sorafenib or lenvatinib therapy
por: Sekiguchi, Shuhei, et al.
Publicado: (2022)

Sorafenib as second‐line treatment option after failure of lenvatinib in patients with unresectable hepatocellular carcinoma
por: Tomonari, Tetsu, et al.
Publicado: (2020)

Technetium-99m-labeled macroaggregated albumin lung perfusion scan for diagnosis of hepatopulmonary syndrome: A prospective study comparing brain uptake and whole-body uptake
por: Zhao, He, et al.
Publicado: (2020)

Combined assessment of myocardial damage and electrical disturbance in chronic heart failure
por: Kadowaki, Shinpei, et al.
Publicado: (2017)

Sorafenib, Lenvatinib, or Lenvatinib Combining PD-1 Inhibitors Plus TACE in Unresectable Hepatocellular Carcinoma: A Retrospective Analysis
por: Zhao, Shu, et al.
Publicado: (2022)

A Case of Unresectable Combined Hepatocellular-Cholangiocarcinoma Successfully Treated with Lenvatinib
por: Osuga, Takahiro, et al.
Publicado: (2022)

Outcome of initial lenvatinib treatment in patients with unresectable anaplastic thyroid cancer
por: Iwasaki, Hiroyuki, et al.
Publicado: (2023)

Back to the Future: Moving Beyond “Mesenchymal Stem Cells”
por: Bianco, Paolo
Publicado: (2011)

Niche Inheritance: A Cooperative Pathway to Enhance Cancer Cell Fitness Through Ecosystem Engineering
por: Yang, Kimberline R, et al.
Publicado: (2014)

Training by Publication: Can Journal be mentors
por: Shyam, Ashok
Publicado: (2016)

Sparse sampling: theory, methods and an application in neuroscience
por: Oñativia, Jon, et al.
Publicado: (2014)

Thinking in circuits: toward neurobiological explanation in cognitive neuroscience
por: Pulvermüller, Friedemann, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_d2vrb8p80mnlt4cn28d672r2lj